Therefore, we speculate that upregulation of GRAMD1B, despite causing decreased SREBP-2 activation and cholesterol biosynthesis, would be beneficial for cancer cells, as it could support their increased uptake, storage, and use of exogenous cholesterol. This evidence concerns the gene SREBF2 and cancer.